Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway
45 p.
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | info:eu-repo/semantics/acceptedVersion biblioteca |
Language: | eng |
Published: |
Society for Endocrinology
2018
|
Subjects: | HER2, TGFB, SMAD, Pituitary adenomas, |
Online Access: | http://hdl.handle.net/11086/550207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|